Combination therapy using a KRAS g12d inhibitor and chemotherapy combinations

TW202633650APending Publication Date: 2026-08-16INCYTE CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141284
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-17
Filing Date
2025-10-23
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072836_001
    Figure TWG2TA001072836_001
  • Figure TWG2TA001072836_002
    Figure TWG2TA001072836_002
Patent Text Reader

Abstract

Provided herein are methods of treating cancer by administering a combination therapy comprising a KRAS G12D inhibitor, folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin.
Need to check novelty before this filing date? Find Prior Art